Artal Group as of Sept. 30, 2019
Portfolio Holdings for Artal Group
Artal Group holds 97 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ww Intl | 22.5 | $560M | 15M | 37.82 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 7.3 | $181M | 60M | 3.01 | |
| Bristol Myers Squibb Call Option (BMY) | 7.1 | $178M | 3.5M | 50.71 | |
| Alibaba Group Hldg Sponsored Ads (BABA) | 3.7 | $92M | 550k | 167.23 | |
| Avantor (AVTR) | 3.5 | $88M | 6.0M | 14.70 | |
| Bank of America Corporation Call Option (BAC) | 3.5 | $88M | 3.0M | 29.17 | |
| Moderna Call Option (MRNA) | 3.3 | $81M | 5.1M | 15.92 | |
| Beigene Sponsored Adr (ONC) | 3.2 | $80M | 650k | 122.46 | |
| Medicines Company | 2.8 | $70M | 1.4M | 50.00 | |
| Morgan Stanley Com New Call Option (MS) | 2.6 | $64M | 1.5M | 42.67 | |
| Acceleron Pharma | 2.4 | $59M | 1.5M | 39.51 | |
| Alnylam Pharmaceuticals (ALNY) | 2.3 | $56M | 700k | 80.42 | |
| Blueprint Medicines (BPMC) | 1.8 | $44M | 600k | 73.47 | |
| NVIDIA Corporation (NVDA) | 1.4 | $35M | 200k | 174.07 | |
| Morphic Hldg (MORF) | 1.3 | $33M | 1.8M | 18.11 | |
| Fate Therapeutics (FATE) | 1.2 | $31M | 2.0M | 15.53 | |
| Gossamer Bio (GOSS) | 1.1 | $27M | 1.6M | 16.79 | |
| Amicus Therapeutics (FOLD) | 1.0 | $24M | 3.0M | 8.02 | |
| Argenx Se Sponsored Adr (ARGX) | 0.9 | $23M | 200k | 113.96 | |
| Rubius Therapeutics | 0.9 | $22M | 2.8M | 7.85 | |
| Atara Biotherapeutics | 0.8 | $21M | 1.5M | 14.12 | |
| Sage Therapeutics (SAGE) | 0.8 | $21M | 150k | 140.29 | |
| Scholar Rock Hldg Corp (SRRK) | 0.8 | $21M | 2.3M | 8.95 | |
| Nektar Therapeutics | 0.8 | $20M | 1.1M | 18.22 | |
| Zillow Group Cl C Cap Stk (Z) | 0.8 | $19M | 650k | 29.82 | |
| Spdr Series Trust S&p Biotech Call Option (XBI) | 0.8 | $19M | 250k | 76.25 | |
| Incyte Corporation Call Option (INCY) | 0.7 | $19M | 250k | 74.23 | |
| Solid Biosciences | 0.7 | $18M | 1.7M | 10.34 | |
| Global Blood Therapeutics In | 0.7 | $17M | 350k | 48.52 | |
| Deciphera Pharmaceuticals | 0.7 | $17M | 500k | 33.94 | |
| Cyclerion Therapeutics | 0.7 | $17M | 1.4M | 12.12 | |
| Mirati Therapeutics | 0.6 | $16M | 200k | 77.91 | |
| Epizyme | 0.6 | $16M | 1.5M | 10.32 | |
| Uber Technologies (UBER) | 0.6 | $15M | 500k | 30.47 | |
| Turning Point Therapeutics I | 0.6 | $15M | 400k | 37.60 | |
| Ascendis Pharma A S Sponsored Adr (ASND) | 0.6 | $14M | 150k | 96.32 | |
| Dicerna Pharmaceuticals | 0.6 | $14M | 1.0M | 14.36 | |
| American Airls Call Option (AAL) | 0.5 | $14M | 500k | 26.97 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $13M | 400k | 32.40 | |
| Iovance Biotherapeutics (IOVA) | 0.5 | $13M | 700k | 18.20 | |
| Realreal (REAL) | 0.5 | $13M | 565k | 22.36 | |
| Tricida | 0.4 | $11M | 360k | 30.87 | |
| Stoneco Com Cl A (STNE) | 0.4 | $10M | 300k | 34.78 | |
| Y Mabs Therapeutics | 0.4 | $10M | 400k | 26.06 | |
| Xencor (XNCR) | 0.4 | $10M | 300k | 33.73 | |
| Delphi Technologies SHS Call Option | 0.4 | $10M | 750k | 13.40 | |
| Fidelity National Information Services (FIS) | 0.4 | $10M | 75k | 132.76 | |
| Audentes Therapeutics | 0.4 | $9.8M | 350k | 28.09 | |
| Accelr8 Technology | 0.4 | $9.3M | 500k | 18.57 | |
| Bluebird Bio | 0.4 | $9.2M | 100k | 91.82 | |
| Albireo Pharma | 0.4 | $9.0M | 450k | 20.00 | |
| Merus N V (MRUS) | 0.4 | $8.9M | 500k | 17.82 | |
| Hookipa Pharma Inc equity | 0.3 | $8.5M | 1.1M | 7.50 | |
| Replimune Group (REPL) | 0.3 | $8.3M | 600k | 13.90 | |
| Minerva Neurosciences | 0.3 | $7.8M | 1.0M | 7.75 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.3 | $7.5M | 1.3M | 5.76 | |
| Translate Bio | 0.3 | $7.4M | 750k | 9.91 | |
| Tcr2 Therapeutics Inc cs | 0.3 | $7.1M | 472k | 15.03 | |
| Kaleido Biosciences Ord (KLDO) | 0.3 | $6.8M | 901k | 7.53 | |
| Springworks Therapeutics (SWTX) | 0.3 | $6.7M | 309k | 21.68 | |
| Fibrogen | 0.3 | $6.7M | 180k | 36.98 | |
| Agenus Com New | 0.3 | $6.5M | 2.5M | 2.58 | |
| Autolus Therapeutics Sponsored Ads (AUTL) | 0.2 | $6.2M | 500k | 12.42 | |
| Denali Therapeutics (DNLI) | 0.2 | $6.1M | 400k | 15.32 | |
| ArQule | 0.2 | $6.1M | 850k | 7.17 | |
| Nio Sponsored Ads (NIO) | 0.2 | $5.9M | 3.8M | 1.56 | |
| Spero Therapeutics (SPRO) | 0.2 | $5.7M | 540k | 10.60 | |
| Krystal Biotech (KRYS) | 0.2 | $5.2M | 150k | 34.73 | |
| Regenxbio Inc equity us cm (RGNX) | 0.2 | $5.2M | 145k | 35.60 | |
| Tg Therapeutics (TGTX) | 0.2 | $5.1M | 900k | 5.62 | |
| Ac Immune Sa SHS (ACIU) | 0.2 | $5.0M | 1.0M | 4.95 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.2 | $4.6M | 150k | 30.90 | |
| Lions Gate Entmnt Corp Cl A Vtg Call Option (LGF.A) | 0.2 | $4.6M | 500k | 9.25 | |
| Restorbio | 0.2 | $4.4M | 500k | 8.84 | |
| Bridgebio Pharma (BBIO) | 0.2 | $4.3M | 200k | 21.47 | |
| Orchard Therapeutics Ads | 0.2 | $4.2M | 350k | 11.88 | |
| Kura Oncology (KURA) | 0.2 | $3.8M | 250k | 15.17 | |
| D Stemline Therapeutics | 0.2 | $3.7M | 360k | 10.41 | |
| Selecta Biosciences | 0.1 | $3.7M | 2.1M | 1.75 | |
| Sangamo Biosciences (SGMO) | 0.1 | $3.7M | 405k | 9.05 | |
| Igm Biosciences (IGMS) | 0.1 | $3.6M | 200k | 17.75 | |
| Douyu International Hldngs L Sponsored Ads | 0.1 | $3.3M | 400k | 8.19 | |
| Alector (ALEC) | 0.1 | $3.2M | 225k | 14.42 | |
| 111 Ads | 0.1 | $3.2M | 650k | 4.87 | |
| Aravive | 0.1 | $3.0M | 400k | 7.50 | |
| Allogene Therapeutics (ALLO) | 0.1 | $2.7M | 100k | 27.26 | |
| Axcella Health Inc equity | 0.1 | $2.5M | 450k | 5.66 | |
| Viking Therapeutics (VKTX) | 0.1 | $2.4M | 350k | 6.88 | |
| Twist Bioscience Corp (TWST) | 0.1 | $2.4M | 100k | 23.88 | |
| Aeglea Biotherapeutics | 0.1 | $2.3M | 300k | 7.69 | |
| Gritstone Oncology Ord (GRTSQ) | 0.1 | $2.2M | 250k | 8.64 | |
| Clovis Oncology | 0.1 | $2.0M | 500k | 3.93 | |
| Square Cl A (XYZ) | 0.1 | $1.9M | 30k | 61.97 | |
| Akebia Therapeutics (AKBA) | 0.1 | $1.7M | 425k | 3.92 | |
| Aduro Biotech | 0.0 | $1.1M | 1.0M | 1.06 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $949k | 111k | 8.59 | |
| Avrobio Ord (AVRO) | 0.0 | $331k | 23k | 14.12 |
